Bank of America’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.3K | Sell |
|
|||||
|
2025
Q1 | $18.1K | Sell |
|
|||||
|
2024
Q4 | $49.5K | Buy |
|
|||||
|
2024
Q3 | $52.4K | Buy |
|
|||||
|
2024
Q2 | $41.5K | Buy |
|
|||||
|
2024
Q1 | $35.2K | Buy |
|
|||||
|
2023
Q4 | $9.35K | Buy |
|
|||||
|
2023
Q3 | $10.8K | Hold |
|
|||||
|
2023
Q2 | $8.07K | Hold |
|
|||||
|
2023
Q1 | $11.8K | Sell |
|
|||||
|
2022
Q4 | $6.72K | Sell |
|
|||||
|
2022
Q3 | $10K | Sell |
|
|||||
|
2022
Q2 | $10K | Sell |
|
|||||
|
2022
Q1 | $15K | Buy |
|
|||||
|
2021
Q4 | $14K | Buy |
|
|||||
|
2021
Q3 | $21K | Sell |
|
|||||
|
2021
Q2 | $40K | Sell |
|
|||||
|
2021
Q1 | $103K | Buy |
|
|||||
|
2020
Q4 | $24K | Buy |
|
|||||
|
2020
Q3 | $20K | Sell |
|
|||||
|
2020
Q2 | $33K | Buy |
|
|||||
|
2020
Q1 | $9K | Sell |
|
|||||
|
2019
Q4 | $27K | Sell |
|
|||||
|
2019
Q3 | $40K | Buy |
|
|||||
|
2019
Q2 | $44K | Sell |
|
|||||
|
2019
Q1 | $112K | Buy |
|
|||||
|
2018
Q4 | $15K | Sell |
|
|||||
|
2018
Q3 | $38K | Buy |
|
|||||
|
2018
Q2 | $19K | Sell |
|
|||||
|
2018
Q1 | $39K | Buy |
|
|||||
|
2017
Q4 | $24K | Sell |
|
|||||
|
2017
Q3 | $16K | Buy |
|
|||||
|
2017
Q2 | $14K | Sell |
|
|||||
|
2017
Q1 | $13K | Sell |
|
|||||
|
2016
Q4 | $9K | Sell |
|
|||||
|
2016
Q3 | $10K | Sell |
|
|||||
|
2016
Q2 | $15K | Sell |
|
|||||
|
2016
Q1 | $15K | Hold |
|
|||||
|
2015
Q4 | $17K | Sell |
|
|||||
|
2015
Q3 | $39K | Sell |
|
|||||
|
2015
Q2 | $48K | Sell |
|
|||||
|
2015
Q1 | $60K | Buy |
|
|||||
|
2014
Q4 | $37K | Sell |
|
|||||
|
2014
Q3 | $84K | Buy |
|
|||||
|
2014
Q2 | $75K | Sell |
|
|||||
|
2014
Q1 | $108K | Buy |
|
|||||
|
2013
Q4 | $16K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $0 | Buy |
|